Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-29Clinical Trial Update: Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG) [Phase 1]
Phase 1 clinical trial update investigating the use of SGLT2 inhibitors to improve myocardial perfusion and symptoms in women with angina du…
-
FDA approval · 2025-10-28FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for Nicardipine hydrochloride from Sagent Pharmaceuticals (ANDA 219608), establishing a generic produc…
-
FDA approval · 2025-10-22FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves an original ANDA for Nicardipine Hydrochloride as a generic product by Caplin Steriles Limited.
-
FDA approval · 2025-09-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for verapamil hydrochloride from Amneal Pharmaceuticals LLC under ANDA210994. This approval authoriz…
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: FAPO-2: Cardiac Patient Monitoring Tool for Clinical Observation and Arrhythmia Detection [NA]
Clinical trial update for FAPO-2, a cardiac patient monitoring tool for clinical observation and arrhythmia detection, enrolling patients wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-09-11FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride from Actavis Pharma, Inc., confirming/expanding the product's regulatory…
-
CLINICAL_TRIALS trial_result · 2025-09-10Clinical Trial Update: Effects of Yangxinshi Pills on the Exercise Tolerance Compared With Trimetazidine in Patients After PCI [Phase 4]
Phase 4 clinical trial comparing Yangxinshi Pills with Trimetazidine in patients after percutaneous coronary intervention has completed, eva…
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Benidipine in Hypertensive and/or Chronic Coronary Syndrome Patients
Benidipine is being studied in patients with chronic coronary syndrome, hypertension, and angina; the trial is currently enrolling by invita…
-
FDA approval · 2025-08-28FDA Approved: LOPRESSOR — Original Application (VALIDUS PHARMACEUTICALS LLC)
FDA approved Lopressor (metoprolol tartrate) via the original application for METOPROLOL TARTRATE by Validus Pharmaceuticals LLC under NDA 2…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Ticagrelor-based De-escalation of Dual Antiplatelet Therapy After Coronary Artery Bypass Grafting [Phase 4]
Phase 4 clinical trial update evaluating ticagrelor-based de-escalation of dual antiplatelet therapy after coronary artery bypass grafting.
-
CLINICAL_TRIALS trial_result · 2025-08-15Clinical Trial Update: Volatilome and Single-Lead Electrocardiogram Optimize Ischemic Heart Disease Diagnosis Using Machine Learning Models
This completed clinical trial evaluated volatile organic compounds and a single-lead electrocardiogram with machine learning to improve isch…
-
FDA approval · 2025-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride by Alembic Pharmaceuticals Inc. The action represents a supplemental reg…
-
CLINICAL_TRIALS research · 2025-08-06Clinical Trial Update: Bidirectional Cohort Study on Improvement of Quality of Life in Patients After Coronary Intervention With Kuanxiong Aerosol
A clinical trial update describes a bidirectional cohort study assessing whether Kuanxiong Aerosol improves quality of life and cardiac func…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina. [Phase 2]
A Phase 2 investigational trial evaluating XC001 delivered via cardiac catheter in subjects with chronic angina is currently recruiting.
-
FDA approval · 2025-07-30FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Atenolol submitted by Rising Pharma Holdings, Inc.
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: The Improving ATTENDance to Cardiac Rehabilitation Trial [NA]
Completed clinical trial assessing approaches to improve attendance at cardiac rehabilitation; results were posted on 2025-07-29.
-
FDA approval · 2025-07-24FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)
The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2025-07-20Clinical Trial Update: Metoprolol and Trimetazidine for Coronary Heart Disease With Angina [NA]
A completed clinical trial evaluating metoprolol and trimetazidine for coronary heart disease with angina has been reported.
-
EMA approval · 2025-07-17EMA Authorised: Ivabradine Zentiva (ivabradine hydrochloride) — Zentiva, k.s.
The EMA authorised Ivabradine Zentiva (ivabradine hydrochloride) for use in angina pectoris and heart failure; Marketing authorization holde…
-
FDA approval · 2025-07-14FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Isosorbide Mononitrate submitted by Chartwell RX, LLC. The action approves changes included in t…
-
FDA approval · 2025-07-14FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Isosorbide Mononitrate submitted by Edenbridge Pharmaceuticals LLC. The action confirms approval…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Intraoperative Echocardiography in Low-Risk CABG Surgery [NA]
This entry notes the status of a clinical trial evaluating intraoperative echocardiography in low-risk CABG surgery, sponsored by the Univer…
-
FDA approval · 2025-07-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride (generic) from Sun Pharmaceutical Industries, Inc. under an ANDA. This a…
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: MCG as a Noninvasive Diagnostic Strategy for Suspected INOCA (MICRO2)
The MICRO2 trial evaluating magnetocardiography (MCG) as a noninvasive diagnostic strategy for suspected INOCA has completed.
-
FDA approval · 2025-07-02FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved a generic diltiazem hydrochloride product from Ingenus Pharmaceuticals under an Original Application (ANDA), expanding access t…